#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Fabry's disease Crigler-Najjar syndrome Primary mediastinal large B-cell lymphoma Autoinflammation with infantile enterocolitis Infantile apnoea Squamous cell carcinoma of the vulva Oesophageal squamous cell carcinoma stage II Skin angiosarcoma Dedifferentiated liposarcoma Erythema multiforme Neuroendocrine cell hyperplasia of infancy Systemic mastocytosis Retinal artery occlusion Depression More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Trials in Disease Paraneoplastic neurological syndrome – Basic Information VEXAS syndrome – Diagnostics Aicardi-Goutieres syndrome – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease Glomerulonephritis membranoproliferative – Trials in Disease Progressive multifocal leukoencephalopathy – Diagnostics Metachromatic leukodystrophy – Diagnostics Factor VIII deficiency – Life with Disease Rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ranibizumab Obinutuzumab Jab-21822 Riociguat Gad20-209-Fsp-A4 Protease Fluoroethyltyrosine F-18 2-DEOXY-D-GLUCOSE Duvakitug Hydrocortisone Ph. Eur. Rbd5044 Sodium VTX2735 SODIUM Mycophenolic Acid Busulfan SODIUM SELENITE PENTAHYDRATE Casirivimab SKB410 Gskvx000000008885 Cat Epithelia Vutrisiran More therapies…

    Learn about Your Condition

    Lymphangioleiomyomatosis Hepato-lenticular degeneration Tendon disorder Encephalitis autoimmune Pulmonary sarcoidosis Uterine cancer Mucopolysaccharidosis II Diverticulitis Dilated cardiomyopathy Critical illness Epiphysiolysis Testicular leiomyosarcoma Adenocarcinoma of colon Haematological malignancy Immunosuppression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

    Recruiting

    2 1 1
    Investigated Drugs:
    • Crinecerfont
    Germany

  • Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Lanreotide
    • Octreotide
    Austria Belgium Bulgaria Denmark Estonia France +10

  • Study of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Opium, Standardized Powdered
    • Tiemonium Methylsulphate
    • Colchicine
    Denmark

  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Efficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small intestine neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    Germany

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany
Previous Page
1 2 3 4 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!